Global Bacterial And Viral Specimen Collection Market Overview: Trends Shaping Growth to 2029
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Market Value Is The Bacterial And Viral Specimen Collection Industry Expected To Reach By 2029, Starting From 2025 Levels?
The bacterial and viral specimen collection market has experienced rapid expansion in recent years. This market is projected to expand from $20.95 billion in 2024 to $23.86 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 13.9%. Historically, this growth can be attributed to several factors, including increased demand for precise and prompt diagnosis, a rise in viral outbreak occurrences, enhanced government funding, an increase in global healthcare spending, and the expansion of telemedicine services.
The market for bacterial and viral specimen collection is anticipated to experience substantial growth over the next few years. It is projected to reach $39.68 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.6%. This expansion during the forecast period is driven by factors such as the broadening of global disease surveillance networks, increased investment in pandemic preparedness, the rising prevalence of infectious diseases, an increase in antimicrobial resistance, and a surge in bacterial infections. Significant trends expected in this period include technological innovations, the integration of digital tracking, the adoption of non-invasive specimen collection methods, the use of microfluidic devices, and the implementation of automated specimen tracking systems.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27219&type=smp
Which Factors And Drivers Are Influencing The Bacterial And Viral Specimen Collection Market In 2025?
The increasing occurrence of infectious diseases is anticipated to drive the expansion of the bacterial and viral specimen collection market in the future. Infectious diseases are conditions resulting from detrimental microorganisms, including bacteria, viruses, fungi, or parasites, capable of direct or indirect human-to-human transmission. This growth in infectious disease prevalence is largely attributable to greater urbanization, which fosters increased population density and more intimate human interaction, thereby accelerating disease spread and establishing favorable environments for pathogens to disseminate more readily within populations. The collection of bacterial and viral specimens aids in managing infectious diseases by supplying crucial samples that allow for accurate detection and diagnosis, thereby supporting prompt and specific medical treatment. For example, data from March 2024, reported by the US-based government agency, the Centers for Disease Control and Prevention, showed an increase in tuberculosis cases from 8,320 in 2022 to 9,615 in 2023, representing a rise of 1,295 cases. Concurrently, the incidence rate climbed from 2.5 to 2.9 per 100,000 persons, indicating a notable year-over-year upward trajectory. Consequently, the expanding occurrence of infectious diseases is fueling the expansion of the bacterial and viral specimen collection market.
What Are The Leading Segments Analyzed In The Bacterial And Viral Specimen Collection Market?
The bacterial and viral specimen collection market covered in this report is segmented
1) By Product: Bacterial Specimen Collection, Viral Specimen Collection
2) By Application: Diagnostics, Research
3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Academic And Research Institutions, Other End User
Subsegments:
1) By Bacterial Specimen Collection: Swabs, Transport Media, Culture Plates & Media, Blood Culture Bottles, Biopsy And Tissue Collection Kits, Urine Collection Containers, Other Specialized Collection Devices
2) By Viral Specimen Collection: Viral Transport Media, Blood Collection Tubes, Saliva Collection Kits, Sputum Collection Containers, Stool Collection Kits, Other Specialized Collection Devices
Which Market Trends Are Creating New Opportunities In The Bacterial And Viral Specimen Collection Industry?
Leading companies within the bacterial and viral specimen collection market are prioritizing the development of novel solutions, specifically viral DNA and RNA extraction kits, to enhance the efficiency, precision, and pace of pathogen identification and examination. These kits serve as laboratory instruments designed to separate and refine viral genetic material from clinical specimens, facilitating precise molecular testing and diagnosis. As an illustration, in April 2024, New England Biolabs, a life sciences firm based in the US, introduced the Monarch Mag Viral DNA and RNA Extraction Kit. This magnetic bead-based purification system is engineered for quick, dependable, and highly sensitive extraction of viral DNA and RNA from diverse sample types, including saliva, respiratory swabs, and enriched wastewater. It supports both manual and automated processes, being compatible with platforms like KingFisher Flex and Agilent Bravo, thereby allowing for high-throughput processing. The kit boosts detection sensitivity even for low viral loads, incorporates carrier RNA to improve recovery, and is appropriate for subsequent applications such as qPCR, RT-qPCR, ddPCR, and next-generation sequencing (NGS). Its objective is to address requirements in infectious disease screening, viral genome sequencing, and environmental monitoring through scalable, hands-free workflows.
Which Major Firms Are Strengthening Their Position In The Bacterial And Viral Specimen Collection Industry?
Major companies operating in the bacterial and viral specimen collection market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Becton Dickinson and Company, Lonza Group AG, Hologic Inc., bioMérieux SA, Quidel Corporation, QIAGEN N.V., DiaSorin S.p.A., Greiner Bio-One International GmbH, Spectrum Solutions LLC, Hardy Diagnostics Inc., EKF Diagnostics Holdings Plc, Trinity Biotech Plc, Puritan Medical Products Company LLC, Wuxi NEST Biotechnology Co. Ltd., Copan Diagnostics Inc., VIRCELL S.L., Medical Wire & Equipment Co. Ltd., HiMedia Laboratories Pvt. Ltd., Longhorn Vaccines and Diagnostics LLC, and Beaver Biomedical Engineering Co. Ltd.
Download The Full Report For Exclusive Market Findings:
Which Region Shows The Highest Potential For Future Expansion In The Bacterial And Viral Specimen Collection Market?
North America was the largest region in the bacterial and viral specimen collection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bacterial and viral specimen collection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Bacterial And Viral Specimen Collection Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27219&type=smp
Browse Through More Reports Similar to the Global Bacterial And Viral Specimen Collection Market 2025, By The Business Research Company
Fire Protection System Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fire-protection-system-global-market-report
Insulation Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report
Sun Care Products Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/sun-care-products-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
